Sovereign by design.
Patient data never leaves the hospital. The model lives on the hospital's own server, the audit log on the hospital's own chain.
LUMEN.
Your hospital's
sovereign brain.
A one-trillion-parameter clinical intelligence, owned by your hospital, running on your hardware, watching every bed in real time.
Sovereign Canadian IP. Patent pending. Deployed inside the hospital, never on a foreign cloud.
The dawn-after-storm sequence.
01
/ 10
00:00 / 01:00
BEAT 01 / 10
04:42, dawn has not yet broken on Riyadh.
The corridor breathes between two emergencies. Twelve beds, twelve patients, one unit that does not sleep.
SCRUB
SCROLL TO ADVANCE
OR TAP A BEAT
Five things only LUMEN does.
A consilium, not a chatbot.
Five specialist AI agents deliberate per complex case the way a real physician's consult does. The deliberation is visible.
One holographic patient state.
Every patient is one unified semantic substrate. Every agent queries the same state. The doctor never re-types the patient's history.
Compressed bedside inference.
A 1-trillion-parameter brain on the hospital server, sub-3-second time-to-first-token, no cloud round trip.
Trilingual native.
Arabic, English, French. Mid-utterance code-switch. The way Arab-world physicians actually speak.
The way a real consult thinks.
Critical Care opens. Pharmacology weighs the regimen. Infectious Diseases comments on the antibiotic. Renal weighs dosing in AKI. Ethics on goals of care. Each adds, the others react, the attending synthesizes. Every claim cites. Every decision lands on a human signature.
Synthetic case for demonstration · constructed with clinical-advisor input · no real patient data
BED 7 · MRN 41-2284 · 04:42 GMT+3
K. PNEUMONIAE BSI · AKI 2 · DELIRIUM
68F, day 3 of admission. Currently meropenem 1 g IV q12h. eGFR 28 mL/min, lactate 3.2 mmol/L, MAP 62 on norepinephrine 0.08 µg/kg/min.
Attending countersign
Khairallah Belkhouja
AUDIT 0xa7e · APPEND-ONLY
Case open · 04:42
ICU bed 7. 68F, day 3. Klebsiella pneumoniae BSI, AKI stage 2, delirium.
The senior consultant requests a Counsel. The case is real, the parameters are real, the deliberation will be visible end-to-end.
SSC 2021 · Crit Care Med
Counsel convenes · 04:43
Five specialists materialize on the same patient state.
Each agent ingests the same holographic substrate. No re-typing of history. No round-trip. The substrate is queryable layer by layer per Patent 134.
Critical Care · opening
"Septic shock from gram-negative source. MAP holding on norepi 0.08. Lactate down-trending. Source presumed hepatobiliary, ultrasound pending."
Specialists speak · 04:43
Each agent contributes from real evidence. Every claim is traceable.
Pharmacology
"eGFR 28 mL/min. Standard meropenem 1 g q8h would over-dose. Recommend reduction to 1 g q24h, renal-adjusted per Sanford."
Sanford Guide · renal dosing
Infectious Diseases
"Klebsiella pneumoniae BSI requires therapeutic AUC throughout dosing interval. Standard renal reduction risks subtherapeutic exposure. Recommend extended infusion 1 g over 4 h q12h."
IDSA · AMR gram-negative
SA stewardship
Renal
"Stage 2 AKI. Trajectory uncertain. Dialysis indication review at 12 h. If CRRT initiated, dose returns to 1 g q12h conventional."
KDIGO 2012 · AKI staging
Ethics
"Family present. Goals of care not yet documented for the current admission. Recommend family meeting within 24 h with the senior consultant."
SCCM · GoC consensus
Disagreement, made visible · 04:44
Pharmacology and Infectious Diseases hold opposing recommendations on the same evidence.
Disagreement vector
Pharmacology: Reduce meropenem to 1 g q24h. Renal clearance dictates exposure.
Infectious Diseases: Maintain therapeutic AUC. Reduce frequency only with extended infusion. 1 g over 4 h q12h.
The Counsel does not collapse this. It surfaces it. The attending sees both arguments before the synthesis assembles.
The disagreement is principled, not noise. Both agents cite real guidelines. The attending's signature resolves it.
Synthesis assembles · 04:46
The contributions converge into a single recommendation, attached to citations and conditions.
Extended-infusion meropenem 1 g over 4 h q12h. Therapeutic drug monitoring at trough 3. Renal consult for dialysis indication review at 12 h. Family meeting within 24 h, goals of care documented per SCCM consensus.
Each clause traces to a citation. Each citation links to a real source. Each source opens in the side drawer for direct reading. The chain holds end to end.
SSC 2021
IDSA AMR
KDIGO 2012
SCCM GoC
Attending signature · 04:48
The decision lands on a human signature. The audit chain crystallizes.
The attending countersigns in the same gesture used for paper orders for thirty years. The signature stroke renders below the diagram. The audit chain entry appends, hospital-owned, portable.
The deliberation is now part of the patient's record. Reproducible. Inspectable. Sovereign.
Audit entry · 0xa7e · 4f9c · 8b21 · 6d04 · e317 · signed LUMEN-CORE-1.0
One holographic patient state, in motion.
01/ 10
Patent 134 · 154 · 207
BEAT 01 / 10
One holographic patient state.
Not five disconnected systems. One semantic substrate every agent queries against.
SCRUB
SCROLL TO ADVANCE
OR TAP A BEAT
Speak the way your physicians actually speak.
The senior consultant in Riyadh switches between Arabic and English mid-sentence. The Tunisian intensivist switches between Arabic, French, and English in the same encounter. The Saudi-trained pharmacist talks to family in Arabic and writes in English.
LUMEN handles all of this natively. Bedside dictation captures the mixed-language utterance, transcribes it, structures it into a chart-language SOAP note, and emits a family-language summary on a separate screen.
This is not translation. This is the way Arab-world medicine actually works, encoded into the substrate.
الإملاء
AR · live
المريض في السرير السابع، عنده إنتان من الكلبسيلة، الـ eGFR is 28، نبدأ meropenem one gram كل اثنا عشر ساعة.
Chart
EN · structured
- S
- Bed 7. Klebsiella sepsis. Family present.
- O
- eGFR 28 mL/min. Lactate 4.1.
- A
- Septic shock, AKI stage 2.
- P
- Meropenem 1 g q12h. Vanco renal-adjusted. Counsel ordered.
Confrère
FR · résumé
Lit 7. Sepsis à Klebsiella, choc septique, IRA stade 2 (eGFR 28 mL/min). Méropénème 1 g toutes les 12 h, vancomycine en dose adaptée. Réunion famille à 09:00.
Microphone live
AR + EN + FR · code-switch detected
Live dictation · ICU bed 7
AR + EN + FR · code-switch
المريض في السرير السابع
، عنده إنتان من الكلبسيلة
, the eGFR is 28
and lactate 4.1
. نبدأ
meropenem 1 gram
كل اثنا عشر ساعة
. Pour la famille, réunion à 9h.
Output · structured destinations
One utterance, three surfaces
Chart · SOAP · English
- S
- ICU bed 7. Klebsiella pneumoniae bloodstream infection. Family present.
- O
- eGFR 28 mL/min. Lactate 4.1 mmol/L. MAP 62 on norepinephrine 0.08.
- A
- Septic shock, AKI stage 2.
- P
- Meropenem 1 g IV q12h, extended infusion. TDM trough 3. Renal consult. Family meeting 09:00.
عائلة المريض · رسالة
حالة والدتكم مستقرة في الحالة الحرجة. عندها التهاب في الدم بدأنا له العلاج المناسب. نطلب اجتماع العائلة الساعة التاسعة لمناقشة خطة العلاج. الفريق الطبي معكم.Confrère · note
Lit 7. Sepsis à Klebsiella pneumoniae, choc septique sous noradrénaline, IRA stade 2 (eGFR 28). Méropénème 1 g IV en perfusion prolongée toutes les 12 h, dosage thérapeutique au creux 3. Avis néphrologique demandé. Réunion famille à 9h.The architecture of trust.
LUMEN is engineered for hospitals that cannot afford cross-jurisdictional data exposure. Saudi military hospitals. Canadian provincial systems. French and German tertiary centres.
We deliver this through a sovereign Canadian patent stack. The model weights are stored in the .col format, a 9.84× compressed AI weight container with cryptographic integrity (USPTO provisional filed 2026-04-04). Inference streams layer-by-layer through the hospital server using Patent 154 DirectStream Local Anchor.
The patient state is encoded on a holographic boundary per Patent 134, queryable by every agent without crossing a database round-trip. When the local model lacks confidence, fallback flows through Patent 41 lattice-bound homomorphic encryption, so plaintext patient data never crosses the hospital firewall even when external compute is consulted.
Compliance posture, aligned at the architecture layer, not at a settings page: Saudi ARDIN, Canadian PIPEDA, GDPR, HIPAA, Quebec Law 25, GCC frameworks.
| No. | Title | Role |
|---|---|---|
| 134 | Holographic Boundary Processor | Patient state on a lower-dimensional boundary. |
| 154 | DirectStream Local Anchor | Layer-by-layer streaming inference. |
| 41 | Lattice-Bound HSE | Homomorphic fallback, plaintext never crosses firewall. |
| .col | Compressed Weight Container | 9.84× measured, USPTO 2026-04-04. |
| 171 | Multi-Agent Counsel Composer | The five-specialist deliberation topology. |
| 207 | Hospital-Owned Audit Chain | Append-only, portable, hospital-owned. |
FIG. 1 / Deployment topology
Patent 134 · 154 · 41 · 207
A deeptech moment, not a SaaS moment.
Three forces aligned in 2026. Sovereign frameworks hardened. One-trillion-parameter open-weight models became deployable on hospital servers. Compression reached the threshold where bedside inference is real. LUMEN ships into this gap.
Frameworks closed the gap.
Saudi ARDIN, Quebec Law 25, GDPR refinements, Canadian provincial residency rules. Cross-jurisdictional clinical data is no longer a tolerated grey zone.
Six frameworks · one architecture1T-parameter, deployable inside.
Open-weight reasoning models reached frontier-class performance in 2025-26. The hospital can now own a 1T-parameter brain, not rent one.
Kimi K2.6 · 1T MoE · open weights9.84× measured, bedside-real.
The .col format reduces a 1T-parameter model footprint to fit hospital-class hardware with cryptographic integrity. USPTO provisional 2026-04-04.
USPTO provisional · 2026-04-04Built by a son and a father. The technologist and the consultant, on the same call sheet.
Two founders, one mandate. The CEO carries the architecture, the patents, and the sovereign deployment. The Co-Founder and Chief Medical Officer carries twenty-eight years of bedside reality and signs every feature against the standard of a senior ICU consultant.
Founder, Chief Executive Officer
Yassine Belkhouja
PulsarOS Intelligence Inc. Carries the LUMEN architecture, the .col format (USPTO provisional 2026-04-04), and the sovereign Canadian deployment.
- Domain
- Sovereign deeptech, on-premise inference, healthcare data architecture
- Patents
- 264 filed, .col format provisional filed USPTO 2026-04-04, 9.84x compression measured
- Languages
- English, French, Arabic
- Mandate
- Architecture, sovereignty, procurement, institutional capital
We build the platform a senior consultant would countersign without hesitation. Anything less is not worth shipping. Yassine Belkhouja, Founder & CEO
Co-Founder, Chief Medical Officer
Khairallah Belkhouja
Senior consultant intensivist. Twenty-eight years of bedside critical care practice in a major Arab-world teaching hospital. Trilingual clinical practice: Arabic to the family, English to the chart, French to the colleague.
- Specialty
- Critical care, adult ICU
- Experience
- Twenty-eight years bedside practice, senior consultant intensivist
- Languages
- Arabic (native), French (native), English (clinical fluency)
- Training
- Faculty of Medicine, University of Tunis (1988-1996); subsequent specialty training in critical care
- Mandate
- Clinical accuracy, bedside register, ICU consultant standard, every feature countersigned
Placeholder, subject to Dr. Belkhouja's edit and final approval:
Twenty-eight years at the bedside teaches you what a chart owes the patient. LUMEN holds that standard, line by line, signature by signature, or it does not ship. Khairallah Belkhouja, Co-Founder & Chief Medical Officer
Father and son. The CEO writes the architecture; the CMO signs every clinical claim. No feature ships unless both signatures hold.
Bookend.
01/ 05
00:00 / 00:30
BEAT 01 / 05
The audit chain holds.
Every query, every reasoning step, every citation, every signature. Append-only, hospital-owned.
SCRUB
SCROLL TO ADVANCE
OR TAP A BEAT
Sovereign Canadian. Patent-backed.
264 + 38
Patents · PulsarOS + Collapse
9.84×
Measured compression · Gemma 4 31B
2026-04-04
USPTO provisional · .col format
DND DISH
Grant in submission · Government of Canada
LUMEN is built by PulsarOS Intelligence Inc., a sovereign Canadian deeptech company headquartered in Ottawa. PulsarOS holds 264 patents across its platform stack. Collapse Technologies Inc. (a 100% PulsarOS subsidiary) holds 38 measured patent embodiments around the .col format, including the 2026-04-04 USPTO provisional. The LUMEN family enters USPTO provisional in 2026-Q3.
The company holds an active Government of Canada DND DISH grant submission for sovereign defence intelligence work that shares architectural ancestors with LUMEN. Sovereign Canadian patent counsel: Smart & Biggar (Ottawa).
For hospitals that buy hardware, not subscriptions.
LUMEN is procured, not subscribed. The hospital buys the server. We provide the platform, the implementation, the fine-tune, and the maintenance. The contract is institutional capex, not SaaS.
Your message reaches a sovereign Canadian server. We never share with a third party. We respond within five business days, in the language you wrote in.